Mode
Text Size
Log in / Sign up
N/A Completed N=81 Randomized Treatment

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

Source: ClinicalTrials.gov NCT04458181 ↗
Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: Satisfaction With Life at Baseline — 17.8; 17.2 units on a scale

Summary

The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) [later renamed "Positive Recovery Journaling" (PRJ)] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.

Outcome Measures

OutcomeResultp-value
PRIMARY
Satisfaction With Life at Baseline
17.8; 17.2
PRIMARY
Satisfaction With Life at 2 Weeks
20.5; 18.6
PRIMARY
Satisfaction With Life at 4 Weeks
19.4; 18.8
PRIMARY
Satisfaction With Life at 8 Weeks
21; 21.2
PRIMARY
Happiness With Recovery at Baseline
8.1; 8.4
PRIMARY
Happiness With Recovery at 2 Weeks
8.3; 8.6
PRIMARY
Happiness With Recovery at 4 Weeks
8.4; 8.4
PRIMARY
Happiness With Recovery at 8 Weeks
8.2; 8.3
PRIMARY
Commitment to Sobriety at Baseline
8.6; 9.2
PRIMARY
Commitment to Sobriety at 2 Weeks
8.8; 9.1
PRIMARY
Commitment to Sobriety at 4 Weeks
8.8; 8.9
PRIMARY
Commitment to Sobriety at 8 Weeks
8.5; 8.6

Eligibility Criteria

Inclusion Criteria

  • meet DSM-V criteria for past-year Substance Use Disorder as primary or secondary diagnosis,
  • English literacy sufficient to make short written lists needed to complete PPJ and homework assessments,
  • minimum 2 weeks sustained abstinence,
  • completed first 2 weeks of treatment at Nuway (approximately 2 weeks), an intensive outpatient substance use disorder treatment program and the recruitment site,
  • agree to be audio recorded or transcription recorded in group meetings and in individual meetings with research staff,
  • currently are clients in the Nuway outpatient program,
  • participants must be English speaking and literacy must be strong enough to write short lists and to understand the questions asked in the questionnaires,
  • participants must have an electronic device that connects to the internet and internet connection for online delivery of intervention during COVID-19.

Exclusion Criteria

  • presence of a psychotic disorder, psychiatric condition (e.g., suicidal ideation), or cognitive impairment (e.g., severe dementia, traumatic brain injury) limiting ability to give consent and/or participate in the study;
  • severe psychiatric illness (current schizophrenia, major depression with suicidal ideation);
  • personality disorders that would interfere with satisfactory participation in or completion of the study protocol,
  • inability to give informed, voluntary consent to participate,
  • lack of sufficient English literacy to participate, defined as inability to make a list of 5 things they did yesterday and inability to understand questionnaire items,
  • any impairment, activity, or situation that in the judgement of the research staff would prevent satisfactory participation in or completion of the study protocol.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04458181). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search